China New Drug Trials Momentum Tapering, Regulatory Changes Looming

New CDE Head, Office

China pharma billionaire net wealth is down in 2022
China trial activity growth slowing? • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D